many clinicians continue to prefer dihydrotachysterol ( dht ) as the initial vitamin d agent of choice in hypoparathyroidism and renal osteodystrophy because of its long history of efficacy and safety .
C0014695
vitamin d
C0020626
hypoparathyroidism